1218 results found
Globally, more than one billion people suffer from high blood pressure. The George Institute for Global Health (TGI) has trialled a new low-dose pill for hypertension that combines three medications in one (Triple Pill), which could change the way high blood pressure is treated around the world.
In July 2023, NHMRC released an updated National Statement on Ethical Conduct in Human Research 2023 (National Statement) incorporating changes to Chapter 2.1: Risk and Benefit and Section 5: Research Governance and Ethics Review and minor consequential changes to other sections of the National Statement. This is the first update to the National Statement since June 2018.
A gathering of our nation’s foremost health and medical researchers has taken place this evening, celebrating their excellence, leadership and extraordinary contributions to the sector in our annual Research Excellence Awards dinner. This year, the ceremony included the celebration of our Biennial Awards and the talent making impact in an area of importance to NHMRC.
Picato® is a prescription gel that treats skin actinic keratosis (potentially pre-cancerous sunspots). The journey to develop this product began in the 1970s when Queensland researcher, Jim Aylward, became interested in a local farming story about the healing properties of the sap of the radium weed Euphorbia peplus (E. peplus) when applied to sunspots on the skin.
The human central nervous system is extremely complex, consisting of about 86 billion neurons,1 and with each neuron capable of forming thousands of connections with other neurons. It is these connections that make the nervous system capable of processing information, but up until the mid-20th century some key aspects of their functions were unknown. NHMRC-funded researchers made critical breakthroughs in our understanding of how neurons communicate with each other, and in doing so provided a foundation for modern neuroscience and neurotransmitter-based medicine.
Professor Emily Banks is focused on those unanswered questions around prevention to really make a difference.
Associate Professor Antony Cooper from the Garvan Institute of Medical Research is a cell and molecular biologist / geneticist with strong interests in elucidating how cellular dysfunction results in human diseases, with a specific interest in neurodegenerative disease such as Parkinson’s Disease. His research on neurodegenerative diseases focuses on understanding the basis of Parkinson’s Disease. Watch his story in the video below.
Over the past century and throughout the world, viral hepatitis emerged as a significant public health issue afflicting hundreds of millions of people and causing severe ill health, liver damage, cancer and death.1
In 2021, an average of 23 people died of stroke each day in Australia, making stroke one of the leading causes of death.1 Acute post-stroke symptoms contribute to this mortality, causing loss of life and independence. A team of NHMRC-funded researchers designed cost-effective and easy to implement protocols for the monitoring and treatment of patients in the 72 hours following a stroke. Implementation of these protocols has led to improvements in survival and health outcomes. They have been adopted into hospitals throughout Australia and in at least 18 countries across the world.
The purpose of this report is to provide a summary of feedback received as part of the national consultation to review NHMRC’s Indigenous Research Excellence Criteria (IREC).
Tooth decay (caries) remains one of the most common health problems for both adults and children in Australia. Collaborative research in oral health is delivering improved basic health outcomes to the most disadvantaged Australians, including Aboriginal and Torres Strait Islander children.
Professor Rachelle Buchbinder is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow. She is the Director and Professor in the Monash University Department of Epidemiology & Preventive Medicine since 2007. Professor Rachelle Buchbinder's clinical practice is in conjunction with research involving multidisciplinary projects relating to arthritis and musculoskeletal condition.
Dr David Gonsalvez heads up a laboratory focused on how glia, the non-neuronal cells in the brain and spinal cord, develop, contribute to neuronal plasticity and respond following injury. David’s lab also focuses on identifying therapeutic targets that may promote the repair of the nervous system in autoimmune diseases such as Multiple Sclerosis (MS).
In 2016 Associate Professor Leonie Quinn relocated to The John Curtin School of Medical Research (ANU, Canberra) to establish the Quinn Group - Cancer Models in the ACRF Department of Cancer Biology and Therapeutics. Associate Professor Quinn is trying to understand how brain cancer develops by using a genetic model through a fly. She hopes to use this information to develop new treatments.
Prof Si Ming Man from The Australian National University and his team investigates the role of innate immunity in infectious diseases and cancer. Professor Man received the NHMRC Research Excellence Award for the highest-ranked Early Career Fellowship (2015) and an NHMRC Research Excellence Award for the highest-ranked Career Development Fellowship Biomedical Level l1 (2019). He also received the 2019 Commonwealth Health Minister's Medal for Excellence in Health and Medical Research and the 2021 CSL Centenary Fellowship.
The purpose of this report is to provide a descriptive analysis of the scope and reach of the National Health and Medical Research Council's (NHMRC) international collaborations across all grant schemes over the past 10 years.